Compare CPSH & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPSH | YI |
|---|---|---|
| Founded | 1984 | 2010 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Building Materials | Retail-Drug Stores and Proprietary Stores |
| Sector | Consumer Discretionary | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.9M | 57.1M |
| IPO Year | 1995 | 2018 |
| Metric | CPSH | YI |
|---|---|---|
| Price | $3.62 | $6.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 150.9K | 14.7K |
| Earning Date | 03-02-2026 | 03-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 113.64 | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $16.41 | N/A |
| Revenue Next Year | $20.16 | N/A |
| P/E Ratio | $126.67 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.40 | $2.48 |
| 52 Week High | $6.85 | $11.17 |
| Indicator | CPSH | YI |
|---|---|---|
| Relative Strength Index (RSI) | 40.97 | 39.82 |
| Support Level | $3.61 | $6.13 |
| Resistance Level | $4.41 | $6.86 |
| Average True Range (ATR) | 0.27 | 0.47 |
| MACD | 0.02 | -0.09 |
| Stochastic Oscillator | 20.55 | 21.10 |
CPS Technologies Corp designs, manufactures, and sells high-performance material solutions for customers across various markets, including transportation, energy, automotive, electronics, telecommunications, aerospace, and defense. The company develops and applies proprietary expertise in metal matrix composites (MMCs), which are engineered materials combining metals and ceramics to achieve enhanced performance properties. It also provides baseplates and housings used in radar, satellite and avionics applications. The company provides lids and heat spreaders used with integrated circuits in Internet switches and routers. The majority of the company's revenue is derived from the sale of its products in the United States of America.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.